The Miriam Hospital

The Miriam Hospital Lifespan Division, a nonprofit hospital division based in Providence, Rhode Island, operates as a federal grant recipient and prime contractor in medical research and clinical training services, with 74% of recent awards held as prime grants or contracts and 26% as sub-recipient positions. The organization competes in full-and-open procurements without set-aside designations and serves primarily as a research and clinical services provider to the National Institutes of Health (NIH), the Department of Veterans Affairs, the Department of the Army, and the Centers for Disease Control and Prevention.

The Miriam Hospital's federal footprint concentrates heavily on NIH-funded research grants. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) leads by award count with 42 recent grants, followed by the National Institute on Drug Abuse with 28 awards and the National Heart Lung and Blood Institute with 23. The Department of Health and Human Services' CDC anchors the dollar base: three CDC awards carry $22.9 million combined potential value, far exceeding the Army's 84 laboratory service task orders (valued at $350 thousand combined). This divergence signals high-value CDC contracts against low-dollar, high-volume Army lab work. The organization is an active research site, providing capacity as both prime recipient and sub-recipient across behavioral health, HIV prevention, substance use, obesity and weight management, maternal health, and cardiovascular disease research.

Representative prime grant work spans clinical and behavioral interventions. The National Institute of Mental Health awarded a $705,322 project grant (CFDA 93.242) on September 16, 2025, for development and evaluation of CHIA, an AI-based chatbot to improve HIV pre-exposure prophylaxis uptake among men who have sex with men through integration of motivational interviewing and transtheoretical model techniques; the project runs through September 15, 2028, with sub-recipients Brown University and University of Florida contributing specialized expertise. The National Institute on Drug Abuse awarded a $186,895 K01 career development grant (CFDA 93.279) on May 1, 2026, for research evaluating optimal settings for integrated wound care, PrEP, and medications for opioid use disorder among people who use drugs, with performance through April 30, 2031, in Providence. The National Institute of Allergy and Infectious Diseases awarded $426,741 on September 12, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) for development and pilot testing of SAI, an AI-based chatbot promoting doxycycline post-exposure prophylaxis uptake among men who have sex with men for bacterial STI prevention, with Brown University as sub-recipient and performance through August 31, 2027.

On the contract side, the organization holds a single-award Indefinite Delivery Contract W912LD04A0004 with the Department of the Army Rhode Island Army National Guard, under which 77 task orders have issued for reference laboratory testing and related services. Recent contract awards from Veterans Integrated Service Network 1 include five low-dollar purchase orders for Qualitative Science Methods Training Program delivery to VA researchers and clinical staff, ranging from $12,600 to $17,850, with completion dates spanning 2023 through June 2027. A $13,754.70 BPA call from the Department of the Army (April 30, 2023) covered fiscal year 2022 laboratory charges delivered by April 30, 2023.

As a sub-recipient, The Miriam Hospital participates in multisite research networks. Named prime grantees placing work include Brown University (multiple sub-awards for research training, qualitative methodology, and clinical site management across HIV prevention, substance use, and behavioral health studies), Rhode Island Hospital (substance use treatment, trauma-informed care, and COBRE center cores), Emma Pendleton Bradley Hospital (pediatric biopsychology core for sleep and circadian rhythms research), Duke University (HIV prevention and treatment optimization), Northwestern University (just-in-time adaptive interventions for binge eating and weight loss), and Emory University (Rhode Island Health Study enrichment). Sub-recipient roles typically involve clinical site oversight, recruitment and retention of study participants, data collection, specimen processing, qualitative analysis, or provision of specialized clinical expertise in infectious disease, behavioral health, or cardiometabolic outcomes.

Activity has grown substantially over the past five years—from 15 awards in 2022 to a peak of 49 in 2024—reflecting scaling of research operations and expanded NIH funding. Twenty-eight awards with completion dates in the next twenty-four months signal ongoing recompete exposure in the grant portfolio. The organization reports combined obligated dollars of $449.5 million against combined potential value of $28.5 million, indicating that invoice-based federal research and clinical service funding far exceeds ceiling values on individual awards, a pattern typical of active research institutions with rolling task order activity and year-to-year grant continuations.